Digital Antigen Test (BARDA)

About Biocrucible

Sapphiros is a private, commercial-stage diagnostics company positioned to disrupt global health testing through scalable, low-cost technology platforms. The company has secured significant strategic partnerships, including a major supply agreement with Roche and a development contract with BARDA, validating its manufacturing capability and product pipeline. With a leadership team boasting deep industry experience and a UK-based facility capable of producing five billion units annually, Sapphiros aims to redefine everyday health management by moving testing out of labs and into consumers' hands.

Therapeutic Areas